Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18485495 | 1.00 | NAAA (0.56) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL17812511 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL9410611 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL43835 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL14522676 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL1218314 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL1218319 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL1400502 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL2430831 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL42509 | 0.98 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113795542-B | Citrate plasticizer composition and resin composition containing the same | 株式会社LG化学 | 2023-07-28 | — | — | CN | disclosed |
| US-20220227961-A1 | CITRATE-BASED PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220227961-A1 | CITRATE-BASED PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING SAME | CS, ACLY, ACSL4 | NAAA 497/4885RAD52 166/4885NPSR1 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.